Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 37.28-23.51-14.3564.8429.76

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 37.28 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84
Mar202029.76

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84
117.88
Mar2020 29.76 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹34,758.2 Cr -3.7% 1.5% 23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-3.7%

1.5%

23.1%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses